583 related articles for article (PubMed ID: 32694610)
1. Non-invasive early detection of cancer four years before conventional diagnosis using a blood test.
Chen X; Gole J; Gore A; He Q; Lu M; Min J; Yuan Z; Yang X; Jiang Y; Zhang T; Suo C; Li X; Cheng L; Zhang Z; Niu H; Li Z; Xie Z; Shi H; Zhang X; Fan M; Wang X; Yang Y; Dang J; McConnell C; Zhang J; Wang J; Yu S; Ye W; Gao Y; Zhang K; Liu R; Jin L
Nat Commun; 2020 Jul; 11(1):3475. PubMed ID: 32694610
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA).
Liang W; Zhao Y; Huang W; Gao Y; Xu W; Tao J; Yang M; Li L; Ping W; Shen H; Fu X; Chen Z; Laird PW; Cai X; Fan JB; He J
Theranostics; 2019; 9(7):2056-2070. PubMed ID: 31037156
[No Abstract] [Full Text] [Related]
3. Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection.
Fiala C; Diamandis EP
BMC Med; 2018 Oct; 16(1):166. PubMed ID: 30285732
[TBL] [Abstract][Full Text] [Related]
4. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.
Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C
Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387
[TBL] [Abstract][Full Text] [Related]
5. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
[TBL] [Abstract][Full Text] [Related]
6. Genomewide copy number alteration screening of circulating plasma DNA: potential for the detection of incipient tumors.
Lenaerts L; Vandenberghe P; Brison N; Che H; Neofytou M; Verheecke M; Leemans L; Maggen C; Dewaele B; Dehaspe L; Vanderschueren S; Dierickx D; Vandecaveye V; Amant F; Vermeesch JR
Ann Oncol; 2019 Jan; 30(1):85-95. PubMed ID: 30371735
[TBL] [Abstract][Full Text] [Related]
7. Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer.
Singh A; Gupta S; Badarukhiya JA; Sachan M
Int J Cancer; 2020 Sep; 147(6):1740-1752. PubMed ID: 32191343
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Power of DNA Methylation Classifiers for Early Detection of Cancer.
Roy D; Tiirikainen M
Trends Cancer; 2020 Feb; 6(2):78-81. PubMed ID: 32061307
[TBL] [Abstract][Full Text] [Related]
9. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers.
Li W; Zhang X; Lu X; You L; Song Y; Luo Z; Zhang J; Nie J; Zheng W; Xu D; Wang Y; Dong Y; Yu S; Hong J; Shi J; Hao H; Luo F; Hua L; Wang P; Qian X; Yuan F; Wei L; Cui M; Zhang T; Liao Q; Dai M; Liu Z; Chen G; Meckel K; Adhikari S; Jia G; Bissonnette MB; Zhang X; Zhao Y; Zhang W; He C; Liu J
Cell Res; 2017 Oct; 27(10):1243-1257. PubMed ID: 28925386
[TBL] [Abstract][Full Text] [Related]
10. Significance of postoperative follow-up of patients with metastatic colorectal cancer using circulating tumor DNA.
Benešová L; Hálková T; Ptáčková R; Semyakina A; Menclová K; Pudil J; Ryska M; Levý M; Šimša J; Pazdírek F; Hoch J; Blaha M; Minárik M
World J Gastroenterol; 2019 Dec; 25(48):6939-6948. PubMed ID: 31908397
[TBL] [Abstract][Full Text] [Related]
11. A Multilocus Blood-Based Assay Targeting Circulating Tumor DNA Methylation Enables Early Detection and Early Relapse Prediction of Colorectal Cancer.
Cai G; Cai M; Feng Z; Liu R; Liang L; Zhou P; ; Zhu B; Mo S; Wang H; Lan X; Cai S; Xu Y; Wang R; Dai W; Han L; Xiang W; Wang B; Guo W; Zhang L; Zhou C; Luo B; Li Y; Nie Y; Ma C; Su Z
Gastroenterology; 2021 Dec; 161(6):2053-2056.e2. PubMed ID: 34487783
[No Abstract] [Full Text] [Related]
12. Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer.
Azad TD; Chaudhuri AA; Fang P; Qiao Y; Esfahani MS; Chabon JJ; Hamilton EG; Yang YD; Lovejoy A; Newman AM; Kurtz DM; Jin M; Schroers-Martin J; Stehr H; Liu CL; Hui AB; Patel V; Maru D; Lin SH; Alizadeh AA; Diehn M
Gastroenterology; 2020 Feb; 158(3):494-505.e6. PubMed ID: 31711920
[TBL] [Abstract][Full Text] [Related]
13. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
14. Grail to pour $1 billion into blood test to detect early cancer.
Sheridan C
Nat Biotechnol; 2017 Feb; 35(2):101-102. PubMed ID: 28178244
[No Abstract] [Full Text] [Related]
15. Early detection and monitoring of cancer in liquid biopsy: advances and challenges.
Xue VW; Wong CSC; Cho WCS
Expert Rev Mol Diagn; 2019 Apr; 19(4):273-276. PubMed ID: 30760042
[No Abstract] [Full Text] [Related]
16. A Step Closer to Cancer Screening by Blood Test.
Thierry AR
Clin Chem; 2018 Oct; 64(10):1420-1422. PubMed ID: 29903875
[No Abstract] [Full Text] [Related]
17. Technical considerations for circulating tumor DNA detection in oncology.
Franczak C; Filhine-Tresarrieu P; Gilson P; Merlin JL; Au L; Harlé A
Expert Rev Mol Diagn; 2019 Feb; 19(2):121-135. PubMed ID: 30648442
[TBL] [Abstract][Full Text] [Related]
18. Next-generation sequencing in liquid biopsy: cancer screening and early detection.
Chen M; Zhao H
Hum Genomics; 2019 Aug; 13(1):34. PubMed ID: 31370908
[TBL] [Abstract][Full Text] [Related]
19. Liquid Biopsy Technique May Allow Early Screening.
Cancer Discov; 2017 Nov; 7(11):1207. PubMed ID: 28903989
[TBL] [Abstract][Full Text] [Related]
20. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]